M. O. Dellacherie

This study shows that lymph node expansion correlates with vaccine efficacy and immunization outcomes, with strong vaccines causing greater and longer-lasting LN expansion.

This paper presents a biomaterial platform that enhances adoptive T cell therapy by engaging the host immune system, leading to better tumor control and long-term protection against solid tumors.

This study demonstrates that a single injection of mesoporous silica rods (MSRs) vaccine can generate potent and durable humoral immunity against small antigens like GnRH and Her2/neu peptides.

The paper introduces a modular vaccine technology (ciVAX) that protects against multiple pathogens and septic shock by using inactivated bacteria and biomaterial scaffolds.